We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Proposed low-dose doxycycline to suppress micro- and nanoplastic-induced inflammation
AI summary Read the abstract
Researchers propose that low-dose doxycycline could help suppress inflammation triggered by micro- and nanoplastic accumulation in human tissues. The study notes that these particles have been detected in blood, placenta, lung, and testes, where they trigger pro-inflammatory signaling pathways. Since tissue clearance of microplastics is insufficient, the authors suggest that targeting the downstream inflammatory response with existing medications warrants further investigation.
Micro- and nanoplastics (MNPs) have been detected in human blood, placenta, lung, and testes. Across in vitro and animal models, MNPs trigger pro-inflammatory signaling (ROS, NF-κB/MAPK, NLRP3) and matrix remodeling. Because tissue clearance is insufficient and removal methods such as apheresis target only circulating particles, interventions that blunt downstream inflammatory pathways are critical. Tetracyclines, including doxycycline and minocycline, act on these same pathways by lowering ROS, suppressing NF-κB and MAPK activity, blocking NLRP3 activation, and inhibiting matrix metalloproteinases (MMPs). Evidence for tetracyclines spans liver, gut, lung, kidney, and brain, indicating broad and consistent mechanistic overlap rather than isolated effects. Doxycycline is safely used long-term at low (sub-antimicrobial) doses (e.g., rosacea, periodontitis) with minimal evidence of resistance selection or microbiota disruption, making it a plausible candidate to blunt MNP-induced inflammation. Despite the convergence, no study has directly evaluated low-dose tetracyclines as potential countermeasures to MNP toxicity. This review proposes a testable hypothesis to evaluate low-dose doxycycline as an intervention against MNP-induced inflammation in high-exposure populations.
More Papers Like This
Diagnosis of micro- and nanoplastic exposure in humans: current status and prospects, technological advances, and clinical implications
AI summary Read the abstract
This review paper summarizes current research on detecting tiny plastic particles (microplastics and nanoplastics) in the human body, including in blood, tissue, and placenta samples. It notes that detecting the smallest particles remains difficult, and discusses studies linking plastic exposure to inflammation and oxidative stress, as well as possible connections to heart, brain, and immune diseases.
Microplastics in Human Tissues: Sources, Distribution, Toxicological Effects, and Health Implications
AI summary Read the abstract
Researchers reviewed the growing body of evidence that microplastics accumulate in human tissues — including lung, blood, placenta, breast milk, and heart tissue — where they can trigger inflammation, oxidative stress, and cell death. The review highlights urgent knowledge gaps around how plastic particles move through the body and what their long-term health effects may be.
Small Plastics, Big Inflammatory Problems.
AI summary Read the abstract
This review examined how micro- and nano-plastics trigger inflammatory responses through interactions with immune cells, finding that particles activate multiple signaling pathways including NF-kB and NLRP3 inflammasome, potentially contributing to chronic low-grade inflammation linked to cardiovascular disease, autoimmune disorders, and cancer.
Direct and Indirect Mitigation Strategies for Microplastic and Nanoplastic Exposure: A Conceptual Framework for Combination Therapeutic Development
AI summary Read the abstract
Tiny plastic particles from our environment may get into our bodies and contribute to inflammation, stress on cells, immune problems, and even brain and heart issues over time. This paper doesn't test new treatments—instead, it proposes a game plan for future research: combining strategies that reduce how much plastic gets into our tissues with treatments that calm the harmful effects those particles might cause. It's an early-stage roadmap for scientists, not a proven fix, but it highlights why tackling microplastic exposure may eventually require a two-pronged medical approach.
Microplastics and human health: exposure pathways, toxicological evidence and mitigation strategies.
AI summary Read the abstract
This review summarizes existing research on tiny plastic particles called microplastics, which have been found in human blood, placenta, lung tissue, breast milk and stool. Lab and animal studies link microplastics to cell damage, inflammation and effects on several organs, but human health data remain limited, and the paper proposes a framework for future risk assessment.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.